Advair (Seretide)


Indications and Reactions:

Role Indications Reactions
Secondary
Allergic Respiratory Disease 66.7%
Chronic Obstructive Pulmonary Disease 33.3%
Alopecia 33.3%
Hallucination 33.3%
Sinusitis 33.3%
Concomitant
Chronic Obstructive Pulmonary Disease 42.0%
Multiple Sclerosis 24.2%
Emphysema 8.3%
Asthma 4.5%
Immunodeficiency Common Variable 3.2%
Product Used For Unknown Indication 2.5%
Hypogammaglobulinaemia 1.9%
Type 2 Diabetes Mellitus 1.9%
Actinic Keratosis 1.3%
Acute Myeloid Leukaemia 1.3%
Depression 1.3%
Ex-smoker 1.3%
Gastrooesophageal Reflux Disease 1.3%
Peripheral Embolism 1.3%
Age-related Macular Degeneration 0.6%
Alpha-1 Anti-trypsin 0.6%
Alpha-1 Anti-trypsin Deficiency 0.6%
Bronchiectasis 0.6%
Bronchitis Chronic 0.6%
Contraception 0.6%
Dyspnoea 18.1%
Drug Ineffective 9.7%
Pneumonia 6.9%
Tremor 6.9%
Ageusia 5.6%
Dysgeusia 5.6%
Nausea 5.6%
Oedema Peripheral 4.2%
Urinary Tract Infection 4.2%
Vaginal Haemorrhage 4.2%
Vomiting 4.2%
Alopecia 2.8%
Application Site Vesicles 2.8%
Asthma 2.8%
Condition Aggravated 2.8%
Myalgia 2.8%
Pain In Extremity 2.8%
Sensory Loss 2.8%
Somnolence 2.8%
Suicidal Ideation 2.8%

Drug Data